Skip to main content

Table 4 Comparison of MRI- and PET/CT-determined tumor staging

From: Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

Tumor stage

MRI-determined staging

PET/CT-determined staging

N0

N1

N2

N3

N0

N1

N2

N3

T1

28 (6.0)

39 (8.3)

8 (1.7)

2 (0.4)

33 (7.0)

30 (6.4)

10 (2.1)

4 (0.9)

T2

18 (3.8)

41 (8.7)

13 (2.8)

9 (1.9)

21 (4.5)

28 (6.0)

18 (3.8)

14 (3.0)

T3

28 (6.0)

153 (32.6)

37 (7.9)

21 (4.5)

45 (9.6)

104 (22.1)

59 (12.6)

31 (6.6)

T4

7 (1.5)

46 (9.8)

13 (2.8)

7 (1.5)

7 (1.5)

34 (7.2)

22 (4.7)

10 (2.1)

Stage I

28 (6.0)

33 (7.0)

Stage II

98 (20.9)

79 (16.8)

Stage III

239 (50.8)

236 (50.2)

Stage IV

105 (22.3)

122 (26.0)

  1. All values are presented as number of patients followed by percentage in parentheses
  2. MRI magnetic resonance imaging, PET/CT positron emission tomography/computed tomography